[Evaluation of the activity of mebendazole in taeniasis caused by Hymenolepis nana in Tunisia].

Abstract

Forty-two Tunisian patients suffering from Hymenolepis nana infection, were treated with 500 mg tablets of mebendazole, 3 times a day, 3 consecutive days for 5 patients (group I) and 4 consecutive days for 37 patients (group II). The faeces were examined during the third and fifth week, after treatment. 18 (42.8%) patients, 2 from group I and 16 from group II, were cured. The tolerance of the product was excellent and there were no adverse side-effects.

• Authors: R Ben-Ismail
• Journal: Bulletin de la Societe de pathologie exotique et de ses filiales (Bull Soc Pathol Exot Filiales) 1984 May-Jun Vol. 77 Issue 3 Pg. 363-8 France
• Vernacular Title: Evaluation de l'activité du mébendazole dans la taeniase a Hymenolepis nana en Tunisie.
• PMID: 6488427 (Publication Type: English Abstract, Journal Article)

Chemical References

• Benzimidazoles
• Mebendazole

Topics

• Adolescent
• Animals
• Benzimidazoles (therapeutic use)
• Child
• Feces (parasitology)
• Female
• Humans
• Hymenolepiasis (diagnosis, drug therapy)
• Hymenolepis
• Male
• Mebendazole (administration & dosage, therapeutic use)
• Parasite Egg Count
• Tunisia